Trials / Unknown
UnknownNCT03334591
Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Anhui Provincial Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hope that after this research, two different treatment methods' curative effects for advanced gastric cancer can be assessed. One is continuous use of apatinib, the other is 5 days' continuous use and 2 days' off of apatinib.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apatinib | Apatinib 500mg with Docetaxel 60mg/m2 |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2019-10-01
- Completion
- 2019-12-01
- First posted
- 2017-11-07
- Last updated
- 2017-11-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03334591. Inclusion in this directory is not an endorsement.